Chesapeake Urology Research Associates is a clinical research site located in Baltimore, Maryland, United States 21204.
Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.
Chesapeake Urology Research Associates has participated in 24 clinical trials with 1 currently active.
Therapeutic areas: Metastatic Castration-Resistant Prostate Cancer, Metastatic Castration-Sensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer.
Sponsors: Sumitomo Pharma America, Inc., Candel Therapeutics, Inc., Spectrum Pharmaceuticals, Inc.
Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Chesapeake Urology Research Associates has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Chesapeake Urology Research Associates has 24 clinical trials on record, with 1 currently active. Their work covers Metastatic Castration-Resistant Prostate Cancer, Metastatic Castration-Sensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer.
Yes — Chesapeake Urology Research Associates holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.